Amanta Healthcar

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE084K01015
NSEID: AMANTA
BSEID: 544502
View on NSE | View on BSE

INR

120.75

0.00 (0.00%)

BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 1.17 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jenburkt Pharma

Medico Remedies

Medicamen Biotec

Amanta Healthcar

Zim Laboratories

Haleos Labs Limi

Albert David

Valiant Laborato

CCME Global

Aptus Pharma

Influx Health.

Why is Amanta Healthcare Ltd ?

Weak Long Term Fundamental Strength with a 9.30% CAGR growth in Operating Profits over the last 5 years

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.30
The company has been able to generate a Return on Equity (avg) of 8.18% signifying low profitability per unit of shareholders funds

Flat results in Mar 26

OPERATING PROFIT TO NET SALES(Q) Lowest at 19.42%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.00%

EBIT Growth (5y)

9.30%

EBIT to Interest (avg)

1.53

Debt to EBITDA (avg)

3.54

Net Debt to Equity (avg)

1.99

Sales to Capital Employed (avg)

0.74

Tax Ratio

29.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.72%

ROCE (avg)

13.00%

ROE (avg)

8.18%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.19

EV to EBIT

15.40

EV to EBITDA

10.58

EV to Capital Employed

1.70

EV to Sales

2.20

PEG Ratio

Dividend Yield

ROCE (Latest)

11.06%

ROE (Latest)

7.60%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING PROFIT TO INTEREST(Q)

Highest at 3.52 times

NET SALES(Q)

Highest at Rs 76.99 cr

-3What is not working for the Company

OPERATING PROFIT TO NET SALES(Q)

Lowest at 19.42%

Loading Valuation Snapshot...

Here's what is working for Amanta Healthcar

Operating Profit to Interest - Quarterly

Highest at 3.52 times

in the last five quarters

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly

Highest at Rs 76.99 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Amanta Healthcar

Operating Profit Margin - Quarterly

Lowest at 19.42% and Fallen

each quarter in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales